Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) EBT Margin (2010 - 2026)

Exelixis (EXEL) posted quarterly EBT Margin of 43.82% for Q2 2026, up 679.0% year-over-year from 5.63% in Q2 2025, and up 3.83% quarter-over-quarter from 42.21% in Q1 2026.

Analysis

Exelixis (EXEL) EBT Margin (2010 - 2026) Analysis & Trends

Exelixis' EBT Margin history runs 17 years deep, the most recent figure standing at 43.82% for Q2 2026.

  • In Q2 2026, EBT Margin rose 679.0% year-over-year to 43.82%; the TTM figure through Apr 2026 stood at 42.23% (up 578.0% YoY), while the FY2026 annual figure was 40.57%, up 914.0% from the prior year.
  • EBT Margin for Q2 2026 stood at 43.82%, up from 42.21% in the prior quarter.
  • The five-year high for EBT Margin was 45.96% in Q2 2024, with the low at 7.41% in Q4 2022.
  • The 5-year median for EBT Margin is 23.94% (2022), against an average of 25.91%.
  • Peak annual rise in EBT Margin reached 2890 bps in 2023, while the deepest fall reached 2112 bps in 2023.
  • Exelixis' EBT Margin stood at 7.41% in 2022, then jumped by 390 bps to 21.48% in 2023, then jumped by 34 bps to 28.68% in 2024, then soared by 47 bps to 42.23% in 2025, then advanced by 4 bps to 43.82% in 2026.
  • Business Quant data shows EXEL's EBT Margin at 43.82% in Q2 2026, 42.21% in Q1 2026, and 42.23% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 35.61%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 35.78%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -528.97%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 18.33%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 13.77%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 12.09%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -2.67%
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 41.78%
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 41.78%
Apr 3, 2026 43.82%
Jan 2, 2026 42.21%
Oct 3, 2025 42.23%
Jul 4, 2025 40.55%
Apr 4, 2025 37.03%
Jan 3, 2025 32.60%
Sep 27, 2024 28.68%
Jun 28, 2024 45.96%
Mar 29, 2024 11.59%
Dec 29, 2023 21.48%
Sep 29, 2023 1.23%
Jun 30, 2023 21.37%
Mar 31, 2023 11.81%
Dec 30, 2022 -7.41%
Sep 30, 2022 22.35%
Jul 1, 2022 21.10%
Apr 1, 2022 23.94%
Oct 1, 2021 16.22%
Jul 2, 2021 32.42%